REGINfo: MSI - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
- Remgro
- RICHEMONT
- RMB Holdings
- Sanlam
- Sasol
- Shoprite
- Standard Bank Group
- Tiger Brands
- Vodacom Group
- WOOLWORTHS
> TA 25
Israel - TA 25
- AVNER OIL
- AZRIELI GROUP
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- ICL
- IFF
- ISRAEL CORP
- KENON
- LEUMI
- MIGDAL INSURANCE
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- OSEM
- PAZ OIL
- PERRIGO
- POALIM
- STRAUSS GROUP
- TEVA

Europe

INDEX SEARCH RESULT

2019.07.01 | 17:30 | Permanent Information Releases / General Company News

NOVARTIS

puce Novartis successfully completes acquisition of Xiidra®, bolstering ophthalmic portfolio - HTML (w)

2019.06.28 | 12:45 | Permanent Information Releases / General Company News

ROCHE

puce CHMP recommends EU approval of Roche’s Tecentriq in combination with Abraxane as an initial treatment for people with PD-L1-positive, metastatic triple-negative breast cancer - HTML (w)

2019.06.20 | 04:30 | Public offerings / Statement of purchases / sales

LAFARGE HOLCIM

puce Lafarge S.A. announces results of its tender offer for US$600,000,000 7.125% notes due 2036 - HTML (w)

2019.06.18 | 18:00 | Permanent Information Releases / Appointments

CLARIANT

puce Clariant AG: Christian Kohlpaintner leaves Clariant after 10 successful years - HTML (w)

2019.06.18 | 08:00 | Permanent Information Releases / General Company News

ROCHE

puce Japan becomes the first country to approve Roche’s personalised medicine Rozlytrek - HTML (w)

2019.06.14 | 08:30 | Permanent Information Releases / Sales and Revenues

NOVARTIS

puce Novartis continues to innovate in CML with long-term treatment-free remission results following Tasigna® use and promising combination data with investigational compound asciminib (ABL001) - HTML (w)

2019.06.12 | 14:05 | Permanent Information Releases / Operations

LAFARGE HOLCIM

puce Lafarge S.A. Announces Any and all Tender Offer For US$600,000,000 7.125% Notes due 2036 - HTML (w)

2019.06.12 | 07:20 | Permanent Information Releases / General Company News

NOVARTIS

puce Cosentyx® provides long-lasting inhibition of radiographic progression in psoriatic arthritis, new Novartis data show - HTML (w)

2019.06.12 | 07:15 | Permanent Information Releases / General Company News

NOVARTIS

puce Novartis Cosentyx® first to show efficacy in all key manifestations of psoriatic arthritis - HTML (w)

2019.06.12 | 07:00 | Permanent Information Releases / General Company News

SIKA

puce SIKA ZEIGT MIT RENOMMIERTEM ARCHITEKTURBÜRO INNOVATIONEN IM 3D-BETONDRUCK - HTML (w)

2019.06.12 | 07:00 | Permanent Information Releases / General Company News

SIKA

puce SIKA PARTNERS WITH TOP ARCHITECT FIRM TO SHOWCASE INNOVATIONS IN 3D CONCRETE PRINTING - HTML (w)

2019.06.11 | 07:03 | Permanent Information Releases / General Company News

ROCHE

puce FDA grants Roche’s Polivy accelerated approval for people with previously treated aggressive lymphoma - HTML (w)

2019.06.11 | 07:00 | Permanent Information Releases / General Company News

ROCHE

puce Änderungen im Verwaltungsrat und in der Konzernleitung von Roche - HTML (w)

2019.06.11 | 07:00 | Periodic information / Internal Control & Corporate Governance

ROCHE

puce Changes in Roche's Board of Directors and Corporate Executive Committee - HTML (w)

2019.06.11 | 04:30 | Permanent Information Releases / General Company News

LAFARGE HOLCIM

puce LafargeHolcim: Scrip Dividend for Financial Year 2018: Announcement of Final Terms - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 1000